---
$id: https://graph.org.ai/products/commodity/51131623
$type: Product
source: UNSPSC
code: "51131623"
title: "Beciparcil"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Beciparcil

**UNSPSC Code**: 51131623
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K90ZOR23P1. European Medicines Agency schedules Beciparcil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05674MIG. Beciparcil generally arises in the molecular formula C12H13NO3S2. The term BECIPARCIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34.) BECIPARCIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule beciparcil under HS 29349990 and SITC 51579. As of Q4 2014, BECIPARCIL remains the US FDA Preferred Term for this commodity. Beciparcil bears US NLM identifiers UMLS ID C0761070 and NCI Concept Code C73225. SMILES: C1C(C(C(C(S1)SC2=CC=C(C=C2)C#N)O)O)O.

